Bio-Connect

ELISA Kit for Osteoglycin (OGN)

SEC688HU
Cloud-Clone Corp.
Product group Assays
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Cloud-Clone Corp.
  • Product Name
    ELISA Kit for Osteoglycin (OGN)
  • Delivery Days Customer
    12
  • Applications
    ELISA
  • Assay Detection Range
    31.2-2,000pg/mL
  • Assay Precision
    Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Osteoglycin (OGN) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with low, middle and high...
  • Assay Sensitivity
    The minimum detectable dose of this kit is typically less than 12.2pg/mL
  • Assay Test Principle
    The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Osteoglycin (OGN). Standards or samples are then added to the appropriate microtiter...
  • Assay Time
    3h
  • Certification
    Research Use Only
  • Protein IDP20774
  • Protein Name
    Mimecan
  • UNSPSC
    41116100
  • Species
    Human

References

  • Osteoglycin Across the Adult Lifespan. Woessner MN et al., 2022 Mar 24, J Clin Endocrinol Metab
    Read this paper
  • Association of SLRPs with carotid artery atherosclerosis in essential hypertensive patients. Yang Y et al., 2018 Sep, J Hum Hypertens
    Read this paper
  • Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway. Hu X et al., 2018 Mar 2, J Exp Clin Cancer Res
    Read this paper
  • Higher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease. Baek SH et al., 2017 Aug, Tohoku J Exp Med
    Read this paper
  • Association of osteoglycin and FAM5C with bone turnover markers, bone mineral density, and vertebral fractures in postmenopausal women with type 2 diabetes mellitus. Tanaka KI et al., 2017 Feb, Bone
    Read this paper